Page 34 - B Cell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

In a recent research article published in the journal of Science Immunology, a team of researchers from Japan performed longitudinal analysis on the cellular composition of receptor-binding domain (RBD) memory B cell subsets and its antibody binding and neutralizing activity against the Beta, Delta, and Omicron variants following the second dose of a messenger ribonucleic acid (mRNA) vaccine.

A team of researchers recently captured memory B cells from a cohort of SARS-CoV-2 convalescent or mRNA-vaccinated individuals to study the evolution of B cell-mediated antibody responses to the N-terminal domain in humans.

Researchers at University Hospitals Seidman Cancer Center and Case Western Reserve University have developed a novel approach to chimeric antigen receptor (CAR) T-cell therapy for B-cell cancers that triples the targeted antigens on cancer cells – a "back up" approach that promises to greatly reduce the potential for antigen escape currently found in CAR T therapies that solely target CD19.

THURSDAY, Jan. 27, 2022 (HealthDay News) -- An initial surge in antibody levels against the Omicron variant after a booster dose of the Moderna COVID vaccine wanes within six months,

THURSDAY, Jan. 27, 2022 (HealthDay News) -- An initial surge in antibody levels against the Omicron variant after a booster dose of the Moderna COVID vaccine wanes within six months,